← Back to Search

Behavioural Intervention

Dance Exercise for Down Syndrome (DANCE-DS Trial)

N/A
Recruiting
Research Sponsored by University of Kansas Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosis of Down syndrome
Be between 18 and 65 years old
Must not have
Unwilling to participate in outcomes assessments
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights
No Placebo-Only Group

Summary

This trial is looking at whether a remote dance exercise program is suitable for young adults with Down Syndrome. Participants will do two 35-minute dance sessions per week for 12 weeks. The study aims to

Who is the study for?
This trial is for young adults with Down Syndrome who lead a sedentary lifestyle and are interested in participating in a remote exercise program. The goal is to see if this program can be done easily and if it's suitable for them.
What is being tested?
The study tests a 12-week online group dance program, where participants will have two 35-minute sessions each week. It aims to check the ease of doing the dance remotely, its impact on fitness and thinking skills, and how much energy it uses.
What are the potential side effects?
Since this intervention involves physical activity through dance, potential side effects may include typical exercise-related issues such as muscle soreness or fatigue. However, specific risks aren't detailed here.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I have been diagnosed with Down syndrome.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am not willing to participate in follow-up assessments.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Adverse Events
Attendance
Retention
Secondary study objectives
6-minute walk test
Energy Expenditure
Episodic Memory
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Decreasing Alzheimer's Risk Through oNline Choreographed Exercise - Down SyndromeExperimental Treatment1 Intervention
Participants will be asked to play attend 35 minute, remotely delivered, group exercise classes using choreographed exercise twice a week for 12 weeks.

Find a Location

Who is running the clinical trial?

University of Kansas Medical CenterLead Sponsor
510 Previous Clinical Trials
176,879 Total Patients Enrolled
4 Trials studying Down Syndrome
302 Patients Enrolled for Down Syndrome
~13 spots leftby Jun 2025